Policy, Research

Axonics (AXNX): Competition Coding Questions

John Leppard, VP Senior Healthcare Analyst
03 March 2023

Summary

We view the competitive pressures for Axonics (AXNX) as manageable following the American Medical Association’s (AMA) disclosure this afternoon that it will create new Category III procedure codes for tibial neurostimulator services [Valencia (private), BlueWind (private)], in that we expect CMS to map these codes to facility-based reimbursement groups that pay ~50% below rates for AXNX sacral nerve procedures.


Want to learn more? Download the Report.

Solutions

Public Policy Research
Identify opportunity and risks driven by public policy.
Fundamental Equity Research
Gain a comprehensive view of global themes, industries, and companies.
Forensic Accounting Research
Understand implications of public company financial reporting.